Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study

Introduction: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a disease with high symptom burden, of unknown etiology, with no established treatment. We observed patients with long-standing ME/CFS who got cancer, and who reported improvement of ME/CFS symptoms after chemotherapy inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Rekeland, Ingrid G., Fosså, Alexander, Lande, Asgeir, Ktoridou-Valen, Irini, Sørland, Kari, Holsen, Mari, Tronstad, Karl J., Risa, Kristin, Alme, Kine, Viken, Marte K., Lie, Benedicte A., Dahl, Olav, Mella, Olav, Fluge, Øystein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201056/
https://www.ncbi.nlm.nih.gov/pubmed/32411717
http://dx.doi.org/10.3389/fmed.2020.00162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201056/
https://www.ncbi.nlm.nih.gov/pubmed/32411717
http://dx.doi.org/10.3389/fmed.2020.00162

Ejemplares similares